The Prospera FDA

What is the most undervalued area for longevity progress we should pursue? Altering regulation around drug approval to accelerate drug development in the longevity space. Where are we today? Where would we like to be? Rapid drug development led to a massive increase in life expectancy in the early 1900’s. After the Thalidomide disaster, the FDA clamped down on drug development and reduced new treatments by 70%. The average cost per drug has skyrocketed in the past decades. What public and private actions have the biggest impact on those goals? Building an alternative structure to the FDA What people, funding, resources, experiments would be required to test this hypothesis? An open source framework, willing participants, and most importantly an economically free zone outside of FDA jurisdiction are required to test this concept.